Tandem Diabetes Care, Inc. Amortization of Debt Issuance Costs and Discounts
Tandem Diabetes Care, Inc. (TNDM) reported Amortization of Debt Issuance Costs and Discounts of $1.90 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-22.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2023-02-22
- Tandem Diabetes Care, Inc. amortization of debt issuance costs and discounts for the quarter ending 2022-12-31 was $501.00K, a 15.17% increase year-over-year.
- Tandem Diabetes Care, Inc. amortization of debt issuance costs and discounts for the quarter ending 2022-09-30 was $499.00K, a 15.24% increase year-over-year.
- Tandem Diabetes Care, Inc. amortization of debt issuance costs and discounts for the quarter ending 2022-06-30 was $458.00K, a 6.26% increase year-over-year.
- Tandem Diabetes Care, Inc. amortization of debt issuance costs and discounts for the quarter ending 2022-03-31 was $438.00K, a 2.34% increase year-over-year.
- Tandem Diabetes Care, Inc. amortization of debt issuance costs and discounts for fiscal 2022 was $1.90M, a 9.79% increase from fiscal 2021.
- Tandem Diabetes Care, Inc. amortization of debt issuance costs and discounts for fiscal 2021 was $1.73M, a 82.89% decline from fiscal 2020.
- Tandem Diabetes Care, Inc. amortization of debt issuance costs and discounts for fiscal 2020 was $10.10M.
- Tandem Diabetes Care, Inc. amortization of debt issuance costs and discounts for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 3 month as first filed | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 6 month as first filed | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 9 month as first filed | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|---|---|---|---|
| 2022-12-31 | $501.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $1.00M derived: sum of 2 quarters · filed 2023-02-22 | $1.46M derived: sum of 3 quarters · filed 2023-02-22 | $1.90M 10-K · filed 2023-02-22 | |||
| 2022-09-30 | $499.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $957.00K derived: sum of 2 quarters · filed 2022-11-02 | $1.40M 10-Q · filed 2022-11-02 | $1.83M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2022-06-30 | $458.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $896.00K 10-Q · filed 2022-08-03 | $1.33M derived: sum of 3 quarters · filed 2023-02-22 | $1.76M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2022-03-31 | $438.00K 10-Q · filed 2022-05-04 | $873.00K derived: sum of 2 quarters · filed 2023-02-22 | $1.31M derived: sum of 3 quarters · filed 2023-02-22 | $1.74M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2021-12-31 | $435.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $868.00K derived: sum of 2 quarters · filed 2023-02-22 | $1.30M derived: sum of 3 quarters · filed 2023-02-22 | $1.73M 10-K · filed 2023-02-22 | |||
| 2021-09-30 | $433.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $864.00K derived: sum of 2 quarters · filed 2022-11-02 | $1.29M 10-Q · filed 2022-11-02 | $5.16M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2021-06-30 | $431.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $859.00K 10-Q · filed 2022-08-03 | $4.72M derived: sum of 3 quarters · filed 2023-02-22 | $8.50M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2021-03-31 | $428.00K 10-Q · filed 2022-05-04 | $4.29M derived: sum of 2 quarters · filed 2023-02-22 | $8.07M derived: sum of 3 quarters · filed 2023-02-22 | ||||
| 2020-12-31 | $3.86M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $7.64M derived: sum of 2 quarters · filed 2023-02-22 | $10.10M 10-K · filed 2023-02-22 | ||||
| 2020-09-30 | $3.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $6.23M 10-Q · filed 2021-11-03 | |||||
| 2020-06-30 | $2.46M 10-Q · filed 2021-08-04 | ||||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $0.00 derived: sum of 2 quarters · filed 2022-02-22 | $0.00 10-K · filed 2022-02-22 | ||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $0.00 10-Q · filed 2020-11-05 | |||||
| 2019-06-30 | $0.00 10-Q · filed 2020-07-30 | ||||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $334.00K derived: sum of 2 quarters · filed 2021-02-24 | $1.03M derived: sum of 3 quarters · filed 2021-02-24 | $1.72M 10-K · filed 2021-02-24 | |||
| 2018-09-30 | $334.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $1.03M derived: sum of 2 quarters · filed 2019-11-04 | $1.72M 10-Q · filed 2019-11-04 | $2.27M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2018-06-30 | $695.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $1.39M 10-Q · filed 2019-08-01 | $1.93M derived: sum of 3 quarters · filed 2020-02-24 | $2.45M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2018-03-31 | $692.00K 10-Q · filed 2019-04-30 | $1.24M derived: sum of 2 quarters · filed 2020-02-24 | $1.76M derived: sum of 3 quarters · filed 2020-02-24 | $2.28M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2017-12-31 | $545.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $1.07M derived: sum of 2 quarters · filed 2020-02-24 | $1.59M derived: sum of 3 quarters · filed 2020-02-24 | $1.88M 10-K · filed 2020-02-24 | |||
| 2017-09-30 | $521.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $1.04M derived: sum of 2 quarters · filed 2018-11-01 | $1.34M 10-Q · filed 2018-11-01 | $1.42M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-06-30 | $523.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-30 | $817.00K 10-Q · filed 2018-07-30 | $897.00K derived: sum of 3 quarters · filed 2019-02-26 | $949.00K derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-03-31 | $294.00K 10-Q · filed 2018-04-26 | $374.00K derived: sum of 2 quarters · filed 2019-02-26 | $426.00K derived: sum of 3 quarters · filed 2019-02-26 | $490.00K derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2016-12-31 | $80.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $132.00K derived: sum of 2 quarters · filed 2019-02-26 | $196.00K derived: sum of 3 quarters · filed 2019-02-26 | $274.00K 10-K · filed 2019-02-26 | |||
| 2016-09-30 | $52.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | $116.00K derived: sum of 2 quarters · filed 2017-10-26 | $194.00K 10-Q · filed 2017-10-26 | $223.00K derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-06-30 | $64.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | $142.00K 10-Q · filed 2017-07-27 | $171.00K derived: sum of 3 quarters · filed 2018-03-01 | $209.00K derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-03-31 | $78.00K 10-Q · filed 2017-04-27 | $107.00K derived: sum of 2 quarters · filed 2018-03-01 | $145.00K derived: sum of 3 quarters · filed 2018-03-01 | $181.00K derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2015-12-31 | $29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $67.00K derived: sum of 2 quarters · filed 2018-03-01 | $103.00K derived: sum of 3 quarters · filed 2018-03-01 | $138.00K 10-K · filed 2018-03-01 | |||
| 2015-09-30 | $38.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $74.00K derived: sum of 2 quarters · filed 2016-11-01 | $109.00K 10-Q · filed 2016-11-01 | $152.00K derived: sum of 4 quarters · filed 2017-03-08 | |||
| 2015-06-30 | $36.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | $71.00K 10-Q · filed 2016-07-28 | $114.00K derived: sum of 3 quarters · filed 2017-03-08 | $156.00K derived: sum of 4 quarters · filed 2017-03-08 | |||
| 2015-03-31 | $35.00K 10-Q · filed 2016-04-28 | $78.00K derived: sum of 2 quarters · filed 2017-03-08 | $120.00K derived: sum of 3 quarters · filed 2017-03-08 | $161.00K derived: sum of 4 quarters · filed 2017-03-08 | |||
| 2014-12-31 | $43.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | $85.00K derived: sum of 2 quarters · filed 2017-03-08 | $126.00K derived: sum of 3 quarters · filed 2017-03-08 | $219.00K 10-K · filed 2017-03-08 | |||
| 2014-09-30 | $42.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $83.00K derived: sum of 2 quarters · filed 2015-10-29 | $176.00K 10-Q · filed 2015-10-29 | $175.81K 10-Q · filed 2014-11-06 | $610.43K derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-06-30 | $41.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $134.00K 10-Q · filed 2015-07-30 | $133.70K 10-Q · filed 2014-07-31 | $568.43K derived: sum of 3 quarters · filed 2016-02-24 | $431.97K derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-03-31 | $93.00K 10-Q · filed 2015-04-30 | $92.88K 10-Q · filed 2014-05-06 | $527.43K derived: sum of 2 quarters · filed 2016-02-24 | $390.97K derived: sum of 3 quarters · filed 2016-02-24 | $404.81K derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2013-12-31 | $434.44K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $297.97K derived: sum of 2 quarters · filed 2016-02-24 | $311.81K derived: sum of 3 quarters · filed 2016-02-24 | $595.00K 10-K · filed 2016-02-24 | |||
| 2013-09-30 | -$136.46K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$122.63K derived: sum of 2 quarters · filed 2014-11-06 | $160.56K 10-Q · filed 2014-11-06 | ||||
| 2013-06-30 | $13.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $297.03K 10-Q · filed 2014-07-31 | |||||
| 2013-03-31 | $283.19K 10-Q · filed 2014-05-06 | ||||||
| 2012-12-31 | $836.00K 10-K · filed 2015-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |